265.58 USD
↘ 0.77 (0.29%)AT CLOSE (11:59 AM EDT)
Johnson & Johnson
JNJNYSE • USD
266.48
↗ 0.90 (0.34%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
266.48
↗ 0.90 (0.34%)
Market: CLOSED
Johnson & Johnson (JNJ) trades at $265.58 per share. There is a divergence between signals — underlying fundamentals rate "Buy" but technical indicators lean "Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (24.8%) and a bullish Golden Cross on the moving averages. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 11, 2026.
Open?$268.03
High?$270.40
Low?$265.25
Prev. Close?$266.35
Volume?4.8M
Avg. Volume?6.4M
VWAP?$267.19
Rel. Volume?0.75x
Bid / Ask
Bid?$265.99 × 400
Ask?$266.97 × 200
Spread?$0.98
Midpoint?$266.48
Valuation & Ratios
Market Cap?640.0B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?30.42
P/B Ratio?7.53
EPS?$8.73
Dividend?1.97%
Ex-Dividend?N/A
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
640.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?69
Short Sent.?78
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.44Safe
Confidence?74%Moderate
Short InterestModerate
Short % of Float?0.90%Low
Short Interest?21.7M
Days to Cover?3.3
Free Float2.4B
Avg Daily Volume6.6M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.09Adequate
Quick Ratio?0.81Weak
Cash Ratio?0.37Low
Debt/Equity?0.58Moderate
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score56/100
P/E?30.4PRICEY▾
Peers75
S&P32
P/B?7.53FAIR▾
Peers63
S&P25
P/S?6.54FAIR▾
Peers50
S&P19
P/FCF?28.8FAIR▾
Peers50
S&P31
EV/EBITDA?19.7FAIR▾
Peers63
S&P27
EV/Sales?6.83HIGH▾
Peers50
S&P21
Returns & Efficiency
ROE?24.8%STRONG▾
Peers63
S&P74
ROA?10.5%STRONG▾
Peers75
S&P76
Cash Flow & Enterprise
FCF?$22.2B
Enterprise Value?$668.6B
Fundamentals ratios updated end of day